The news cycle has brought up the cyclospora protozoan outbreak for weeks but has not told us why America was so ill-prepared for another infectious disease threat.

The Scale of the Disaster

As of mid-July 2026, the United States is in the grip of the worst cyclosporiasis outbreak in recent memory. The majority of cases are confirmed by multiplex GI pathogen panels like the BioFire FilmArray Gastrointestinal (GI) Panel which explicitly tests for Cyclospora cayetanensis and has replaced the old stool acid fast stain. The numbers tell the story:

Michigan alone reports over 5,000 cases and 102 hospitalizations

Ohio has logged more than 1,240 cases

Indiana: 320+ cases; Kentucky: 190+; West Virginia: 139

Nationwide, the CDC acknowledges 1,644 confirmed infections across 34 states, with 94 hospitalizations—and that's the official count, which the agency itself admits is a dramatic undercount

The source? Taylor Farms iceberg lettuce imported from central Mexico, served at Taco Bell restaurants across the Midwest and beyond. The company has admitted responsibility. The lettuce has been pulled. But for thousands of Americans now enduring explosive, watery diarrhea, crippling abdominal cramps, nausea, and low-grade fever that can persist for a month or longer, the damage is done.

Here's what makes this outbreak particularly galling: the treatment has been known for decades, and it's sitting right there in The Wellness Company's Medical Emergency Kit.

TMP-SMX: The Undisputed Treatment of Choice

Let's be absolutely clear—this is not a matter of debate or alternative medicine. The CDC and every major infectious disease authority agree: trimethoprim-sulfamethoxazole (TMP-SMX), sold as Bactrim™, Septra™, or Cotrim™, is the treatment of choice for cyclosporiasis. Period.

The standard adult regimen is straightforward:

TMP 160 mg plus SMX 800 mg (one double-strength tablet), orally, twice daily, for 7–10 days.

That's it. A simple, well-tolerated, generic antibiotic that has been in clinical use for over half a century. For pediatric patients, the weight-based dosing is equally well-established. The drug works by sequentially blocking two steps in the bacterial folate synthesis pathway, and against Cyclospora cayetanensis, it is remarkably effective.

The alternatives? They barely deserve the name:

Ciprofloxacin is listed as a backup option, but it's a fluoroquinolone with a black box warning for tendon rupture and permanent nerve damage—hardly a first-line choice

Nitazoxanide shows only 71–87% efficacy, meaning roughly one in four to one in three patients won't clear the infection

Observation and symptomatic treatment alone leaves patients suffering for weeks to over a month, with the characteristic relapsing pattern where symptoms seem to resolve only to return with a vengeance